NUVB
Nuvation Bio Inc.
Latest Form 4:Sale$753KbyMarkel Stacy (CHIEF PEOPLE OFFICER) · filed Jun 24, 2026
Nuvation Bio Inc. (NUVB) has 9 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 17, 2026.
The most active filer is CHIEF REGULATORY OFFICER Wentworth Kerry with 3 filings. Insiders have net sold $2.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:David T. Hung
- Employees:273
- HQ:New York City, NY, US
- IPO:2020-08-26
Insider Buying
$118K
reported purchases (SEC code P)
Insider Selling
$2.8M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$2.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Markel StacyFirst filing | CHIEF PEOPLE OFFICER | Sale | 125,000 | $753K | Jun 24 | SEC ↗ |
| CHIEF REGULATORY OFFICER | Sale | 63,000 | $379K | Jun 24 | SEC ↗ | |
Sauvage PhilippeFirst filing | Chief Financial Officer | Sale | 47,668 | $286K | Jun 24 | SEC ↗ |
Mashal RobertFirst filing | Director | Purchase | 25,000 | $118K | Jun 12 | SEC ↗ |
| CHIEF REGULATORY OFFICER | Sale | 36,750 | $184K | Apr 21 | SEC ↗ | |
Liu DongfangFirst filing | CHIEF MEDICAL OFFICER | Sale | 50,000 | $251K | Apr 21 | SEC ↗ |
Wentworth KerryFirst filing | CHIEF REGULATORY OFFICER | Sale | 200,000 | $904K | Apr 8 | SEC ↗ |
Related companies
Nuvation Bio Inc. is in the Healthcare sector.